文献速递关节外科创伤骨科

1.5期股骨柄混合固定与两期置换关节成形术治疗假体周围髋关节感染的对比分析:1.5期置换是否等效

A comparative analysis of 1.5-stage stem hybrid fixation versus two-stage exchange arthroplasty for periprosthetic hip infection : is a 1.5-stage exchange equivalent?
PubMed 文献 · Bone Joint J · 2025-06-01

该回顾性单中心研究比较了1.5期股骨柄混合固定(n=43)与两期置换髋关节成形术(n=30)治疗假体周围髋关节感染的73例患者,随访平均454天。1.5期组因感染再次翻修的比例显著更高(80% vs 0%;p=0.011),手术类型并非再次翻修的显著预测因素。作者初步数据提示选择性1.5期置换与更多感染相关再次翻修相关,但需考虑其单次手术的潜在获益。

要点

  • 1.5期组因感染再次翻修比例显著高于两期组(80% vs 0%;p=0.011)。
  • 1.5期组ASA III或IV级比例更高(77% vs 50%;p=0.025),既往翻修次数更多(平均1.5 vs 0.7;p=0.012)。
  • 两期组随访时间(650 vs 317天;p=0.002)和手术时间(501.3 vs 267.2分钟;p<0.001)显著更长。

核心结论

  • 作者初步数据提示,选择性1.5期置换与两期置换患者相比,因感染导致的再次翻修显著更多。
  • 作者承认1.5期策略尤其在高危患者中因只需单次手术而有潜在获益,但在与这些患者沟通时必须考虑更高的再感染率。

研究设计与样本

  • 回顾性单中心研究,纳入2019年3月至2023年5月期间接受1.5期股骨柄混合固定(n=43)或两期置换髋关节成形术(n=30)的73例患者。
  • 比较两组人口学信息及感兴趣变量,采用逻辑回归评估再次翻修的预测因素。
  • 平均随访454天(23至1,620天)。

主要发现

  • 两组队列除1.5期组ASA III或IV级比例更高(77% vs 50%;p=0.025)外无显著差异。
  • 1.5期组既往翻修次数更多(平均1.5 vs 0.7;p=0.012)。
  • 两期组平均随访时间(650 vs 317天;p=0.002)和平均手术时间(501.3分钟(360至660) vs 267.2分钟(150至420);p<0.001)显著更长。
  • 1.5期组因假体周围感染作为再次翻修原因的比例显著更高(80% vs 0%;p=0.011)。
  • 术后成功或失败(MSIS结局)及死亡率无统计学显著差异,手术类型并非再次翻修的显著预测因素。

关键数值与推荐

  • 1.5期组因感染再次翻修比例80% vs 两期组0%(p=0.011)。
  • 1.5期组ASA III或IV级比例77% vs 两期组50%(p=0.025)。
  • 1.5期组既往翻修次数平均1.5 vs 两期组0.7(p=0.012)。
  • 两期组平均随访650天 vs 1.5期组317天(p=0.002)。
  • 两期组平均手术时间501.3分钟(360至660) vs 1.5期组267.2分钟(150至420)(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Two-stage exchange arthroplasty is frequently used to treat periprosthetic hip infection. Nevertheless, particularly in high-risk patients, there has been increased attention towards single-surgery options such as 1.5-stage exchange. Therefore, we sought to compare 1.5- and two-stage patients and determine: 1) baseline demographic details, comorbidities, infection, surgical, and inpatient characteristics; 2) re-revision rates and causes, hip pain and implant loosening of surviving implants, success/failure according to the Musculoskeletal Infection Society (MSIS) outcome reporting tool, and mortality at latest follow-up; and 3) whether the type of surgery (1.5- vs two-stage) is a re-revision predictor. METHODS: We undertook a retrospective review of 73 patients who underwent either 1.5-stage stem hybrid fixation (n = 43) or two-stage exchange hip arthroplasty (n = 30) at a single institution (March 2019 to May 2023). Demographic information and variables of interest were compared between groups. Predictors of re-revision were assessed with logistic regression. The mean follow-up was 454 days (23 to 1,620). RESULTS: Our cohorts were not significantly different, except for a higher proportion of 1.5-stage patients classified as American Society of Anesthesiologists (ASA) grade III or IV (77% vs 50%; p = 0.025). There were more prior revisions among 1.5-stage patients (mean 1.5 vs 0.7; p = 0.012), whereas mean length of follow-up and mean operating time were significantly longer among two-stage patients (650 vs 317 days, p = 0.002; and 501.3 (360 to 660) vs 267.2 mins (150 to 420), p < 0.001, respectively). In the 1.5-stage group, there was a significantly higher proportion of periprosthetic infections as a cause of re-revision (80% vs 0%; p = 0.011). Postoperative success or failure (MSIS outcome) and mortality rates were not statistically significantly different. The type of surgery was not a significant re-revision predictor. CONCLUSION: Our preliminary data suggest that our selective prescription of 1.5-stage revision was associated with significantly more re-revisions due to infection when compared with two-stage patients. We acknowledge the potential benefits of the 1.5-stage strategy, especially among high-risk patients, as it involves a single operation; however, higher reinfection rates must be considered when counselling these patients.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Villa JM, Hosseinzadeh S, Rajschmir K, et al. A comparative analysis of 1.5-stage stem hybrid fixation versus two-stage exchange arthroplasty for periprosthetic hip infection : is a 1.5-stage exchange equivalent? Bone Joint J. 2025. PMID: 40449559. doi:10.1302/0301-620X.107B6.BJJ-2024-1088.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。